Marissa Li, MD¹, Terra Lasho, PhD², Alejandro Ferrer, PhD^3*, Naseema Gangat, MBBS², Aref Al-Kali, MD², Abhishek A. Mangaonkar, MBBS², Michelle Elliot, MD^4*, Mark Litzow, MD², William J Hogan, MB, BCh⁵, Animesh Pardanani, MBBS, PhD², Alexandra Wolanskyj-Spinner, MD^6*, Kaaren K. Reichard, MD^7*, Matthew T Howard, MD^2*, Rebecca L. King, MD⁸, Mithun Vinod Shah, MD, PhD², Hassan B. Alkhateeb, MD^2*, Kebede H. Begna, MD², Ayalew Tefferi, MD², Christy Finke, BS^2*, Moritz Binder, MD, MPH², Horatiu Olteanu, MD, PhD^8* and Mrinal M. Patnaik, MD, MBBS²

¹Internal Medicine, Mayo Clinic, Rochester, MN
²Division of Hematology, Mayo Clinic, Rochester, MN
³Center for Individualized Medicine, Department of Health Sciences Research, Mayo Clinic, Rochester
⁴Mayo Clinic, Rochester, MN
⁵Mayo Clinic Rochester, Division of Hematology, Rochester, MN
⁶Department of Hematology, Mayo Clinic, Rochester, MN
⁷Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
⁸Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN

Danielle Hammond, MD¹, Courtney D. DiNardo, MD, MSc², Marina Konopleva, MD, PhD³, Gautam Borthakur, MD¹, Jorge M. Ramos Perez, MD^1*, Veronica A Guerra, MD¹, Rashmi Kanagal-Shamanna, MD⁴, Shilpa Paul, PharmD^5*, Kiran Naqvi, MD, MPH¹, Koji Sasaki, MD¹, Elias Jabbour, MD¹, Naveen Pemmaraju, MD¹, Tapan M. Kadia, MD¹, Farhad Ravandi, MBBS¹, Naval Daver, MD¹, Zeev E. Estrov, MD¹, Sherry A. Pierce, BSN, BA^1*, Hagop M. Kantarjian, MD¹, Guillermo Garcia-Manero, MD¹ and Guillermo Montalban-Bravo, MD^1*

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX
³Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX
⁴Department of Hematopathology, Division of Pathology/Lab Medicine, University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX

Uwe Platzbecker, MD¹, Yiming Zhu^2*, Xianwei Ha^2*, Alberto Risueño^3*, Esther Chan^2*, George Zhang^2*, Diana R. Dunshee^4*, Melih Acar^4*, Jeevan K. Shetty^5*, Rodrigo Ito^2*, Kyle MacBeth², Valeria Santini⁶, Maciej W. Garbowski^7*, Pierre Fenaux, MD, PhD⁸ and Martin Schwickart^2*

¹Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany
²Bristol Myers Squibb, Princeton, NJ
³BMS Center for Innovation and Translational Research Europe (CITRE), a Bristol Myers Squibb Company, Seville, Spain
⁴Formerly Bristol Myers Squibb, Princeton, NJ
⁵Celgene International Sàrl, a Bristol-Myers Squibb Company, Boudry, Switzerland
⁶Azienda Ospedaliero Universitaria Careggi, University of Florence, Florence, Italy
⁷Department of Haematology, University College London, London, United Kingdom
⁸Service d’Hématologie Séniors, Hôpital Saint-Louis, Assistance Publique des Hôpitaux de Paris and Université Paris 7, Paris, France

Joshua F. Zeidner, MD¹, Flora Mazerolle, MSc^2*, Jill A. Bell, PhD, MS^3*, Lauren E. Cain, MHS, ScM, PhD^3*, Douglas V. Faller^3*, Mehul Dalal, PhD^4*, Antoine Regnault, PhD^2* and Robert J. Fram^3*

¹University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, NC
²Modus Outcomes, Lyon, France
³Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA
⁴Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Ltd., Cambridge, MA

Andrew H. Wei, MBBS, PhD¹, Jordi Esteve, MD, PhD², Kimmo Porkka³, Steve Knapper^4*, Norbert Vey, MD⁵, Sebastian Scholl^6*, Guillermo Garcia-Manero, MD⁷, Martin Wermke^8*, Jeroen Janssen^9*, Elie Traer¹⁰, Sun Loo^11*, Rupa Narayan^12*, Natalia Tovar^13*, Mika Kontro^3*, Oliver Ottmann⁴, Siyan Xu^14*, Serena Liao^14*, Andrew Stein^14*, Fariba Khanshan^14*, Purushotham Naidu^15*, Na Zhang^14*, Anisa Mohammed^15*, Mikael L. Rinne^14*, Haiying Sun^15*, Andrew M. Brunner, MD¹² and Uma Borate¹⁰

¹The Alfred Hospital and Monash University, Melbourne, VIC, Australia
²Hematology Department, Hospital Clínic de Barcelona, Barcelona, Spain
³Helsinki University Hospital Comprehensive Cancer Center, Department of Hematology, Helsinki, Finland
⁴Cardiff University, Cardiff, United Kingdom
⁵Institut Paoli-Calmettes, Marseille, France
⁶University Hospital Jena, Jena, Germany
⁷MD Anderson Cancer Center, Houston, TX
⁸University Hospital Dresden, Dresden, Germany
⁹Amsterdam University Medical Centers, VU University Medical Center, Amsterdam, Netherlands
¹⁰Oregon Health & Science University, Portland, OR
¹¹The Alfred Hospital, Melbourne, VIC, Australia
¹²Massachusetts General Hospital, Boston, MA
¹³Hospital Clínic, Barcelona, Spain
¹⁴Novartis Institutes for BioMedical Research, Cambridge, MA
¹⁵Novartis Pharmaceuticals Corporation, East Hanover, NJ

Claire Jouzier^1*, Amina Cherait^2*, Pascale Cony-Makhoul, MD^3*, Sylvain Thepot, MD^4*, Thomas Cluzeau, MD, PhD^5*, Aspasia Stamatoulas Bastard, MD^6*, Pierre Peterlin, MD^7*, Agnes Guerci Bresler, MD^8*, Sophie Dimicoli-Salazar, MD^9*, Gian-Matteo Pica, MD^10*, Stephane Cheze, MD^11*, Clémence Santana, MD^12*, Fatiha Chermat^13*, Pierre Fenaux, MD, PhD¹⁴ and Sophie Park, MD, PhD^1*

¹Service d'Hématologie, CHU Grenoble Alpes, Grenoble, France
²Service d'Hématologie Séniors, Hôpital Saint-Louis, Paris, CO, France
³Service d'Hématologie, Centre Hospitalier Annecy-Genevois, Pringy, France
⁴Service des Maladies du Sang, CHU Angers, Angers, France
⁵Service d'Hématologie Clinique, Centre Hospitalier Universitaire de Nice, Nice, France
⁶Service d'Hématologie, Centre Henri Becquerel, Rouen, France
⁷Service d'Hématologie Clinique, Centre Hospitalier Universitaire Nantes, Nantes, France
⁸Service d'Hématologie Clinique, Centre Hospitalier Universitaire Brabois, Nancy, France
⁹Service des Maladies du Sang, Centre Hospitalier Universitaire Haut-Lévèque, Bordeaux, France
¹⁰Service d'Hématologie Clinique, Centre Hospitalier Métropole Savoie, Chambery, France
¹¹Service d'Hématologie Clinique, CHU Côte de Nacre, Caen, France
¹²Service d'Hématologie, Centre Léon Bérard, Lyon, France
¹³Service d'Hématologie Séniors, Hôpital Saint-Louis, Paris, France
¹⁴Hôpital Saint-Louis, Paris, France

John Mascarenhas, MD¹, Claire Harrison, DM, FRCPath², Jean-Jacques Kiladjian, MD, PhD³, Ruben Mesa, MD⁴, Rami S. Komrokji, MD⁵, Steffen Koschmieder, MD⁶, Alessandro Vannucchi, MD⁷, Tymara Berry, MD^8*, Laurie Sherman, BSN⁸, Souria Dougherty, BS, MBA^8*, Libo Sun, PhD^8*, Fei Huang, PhD^8*, Ying Wan, PhD^8*, Faye Feller, MD⁸, Aleksandra Rizo, MD, PhD⁸ and Srdan Verstovsek, MD, PhD⁹

¹Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
²Guy's and St Thomas' Hospital, London, United Kingdom
³Hopital Saint-Louis, Paris, France
⁴University of Texas Health Science Center at San Antonio, San Antonio, TX
⁵H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁶RWTH Aachen University, Aachen, Germany
⁷AOU Careggi and University of Florence, Florence, Italy
⁸Geron Corporation, Parsippany, NJ
⁹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Anne Sophie Kubasch^1,2,3*, Aristoteles Giagounidis^1,3,4, Georgia Metzgeroth^5*, Anna Jonasova, MD, PhD^6*, Regina Herbst, MD^7*, Jose Miguel Torregrosa Diaz^8*, Benoit De Renzis, MD^9*, Katharina S. Götze^1,3,10,11, Marie-Luise Huetter-Kroenke, MD^12*, Marie-Pierre Gourin^13*, Bohrane Slama, MD^14*, Sophie Dimicoli-Salazar, MD^15*, Pascale Cony-Makhoul, MD^16*, Kamel Laribi, MD^17*, Sophie Park, MD, PhD^18*, Katja Jersemann^19*, Dorothea Schipp^20*, Klaus H. Metzeler, MD²¹, Oliver Tiebel, MD^22*, Katja Sockel, MD^1,23*, Silke Gloaguen, Msc^1,3*, Anna Mies^24*, Fatiha Chermat^25*, Christian Thiede, MD²⁴, Rosa Sapena^26*, Richard F. Schlenk^27,28, Pierre Fenaux, MD, PhD^3,29,30, Uwe Platzbecker, MD^1,3,31 and Lionel Ades, MD, PhD^3,25,30

¹German MDS Study Group (D-MDS), Leipzig, Germany
²Department of Hematology, Cellular Therapy and Hemostaseology, University Hospital Leipzig, Leipzig, Germany
³The European Myelodysplastic Syndromes Cooperative Group (EMSCO), Leipzig, Germany
⁴Department of Oncology, Hematology and Palliative Care, Marienhospital Düsseldorf, Düsseldorf, Germany
⁵Department of Hematology and Oncology, University Medical Centre,, Mannheim, Germany
⁶Charles University General Hospital 1st Department of Medicine, Prague, Czech Republic
⁷Department of Internal Medicine III, Klinikum Chemnitz, Chemnitz, Germany
⁸Department of Hematology and Oncology, CHU de Poitiers, Poitiers, FRA
⁹Service d'Hématologie Clinique Adulte, Clermont Ferrand, FRA
¹⁰Department of Medicine III, Technical University of Munich, Munich, Germany
¹¹German Cancer Consortium (DKTK), German Cancer Center (DKFZ), Heidelberg, Germany
¹²Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany
¹³CHU Limoges, Limoges, FRA
¹⁴Oncologie Médicale-Hématologie Clinique, Centre Hospitalier Departemental, Avignon, France
¹⁵University Hospital Bordeaux, Pessac, France
¹⁶Service d'Hématologie, Centre Hospitalier Annecy-Genevois, Pringy, France
¹⁷Centre Hospitalier Du Mans, Le Mans, France
¹⁸Department of Hematology, CHU Grenoble, Grenoble Cedex 9, France
¹⁹GWT-TUD GmbH, Dresden, Germany
²⁰DS-Statistics, Rosenthal-Bielatal, Germany
²¹Laboratory for Leukemia Diagnostics, Department of Hematology and Oncology, University Hospital, LMU Munich, Munich, Germany
²²Institute of Clinical Chemistry and Laboratory Medicine, Medical Faculty, Technical University Dresden, Dresden, Germany
²³Dept. of Internal Medicine I, University Hospital Carl Gustav Carus Dresden, Dresden, Germany
²⁴Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany
²⁵Service d'Hématologie Séniors, Hôpital Saint-Louis, Paris, France
²⁶Groupe Francophone des Myélodysplasies, Paris, France
²⁷Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany
²⁸German Cancer Research Center, NCT-clinical trials office, Heidelberg, Germany
²⁹Hôpital Saint-Louis, Paris, France
³⁰Groupe Francophone des Myélodysplasies (GFM), Paris, France
³¹Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany

Koji Sasaki, MD¹, Elias Jabbour, MD², Guillermo Montalban Bravo, MD², Nicholas J. Short, MD¹, Rashmi Kanagal-Shamanna, MD³, Tapan M. Kadia, MD¹, Gautam Borthakur, MD², Naveen Pemmaraju, MD⁴, Jorge E. Cortes, MD², Farhad Ravandi, MBBS¹, Yesid Alvarado, MD⁵, Kelly S. Chien, MD², Hui Yang, MD, PhD², Hagop M. Kantarjian, MD² and Guillermo Garcia-Manero, MD¹

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX
⁴University of Texas, MD Anderson Cancer Center, Houston, TX
⁵Department of Leukemia, MD Anderson Cancer Center, Houston, TX

Jennifer Teichman, MD¹, Michelle Geddes, MD², Nancy Zhu, MD^3*, Mary-Margaret Keating, MD, FRCPC⁴, Mitchell Sabloff, MSc, MD, FRCPC⁵, Grace Christou, MD⁵, Brian Leber, MD⁶, Dina Khalaf, BSc, MSc, MD⁶, Eve St-Hilaire, MD^7*, Nicholas Finn, MD⁸, April Shamy, MD⁹, Karen W.L. Yee, MD¹⁰, John M. Storring, MD¹¹, Thomas J. Nevill, MD¹², Robert Delage, MD¹³, Mohamed Elemary, MD^14*, Versha Banerji, MD¹⁵, Lee Mozessohn, MD¹⁶, Lisa Chodirker, MD^16*, Liying Zhang, PhD^17*, Mohammed Siddiqui^16*, Anne Parmentier, BA^18*, Heather A. Leitch, MD¹⁹ and Rena J. Buckstein, MD, FRCPC²⁰

¹Department of Medicine, University of Toronto, Toronto, ON, Canada
²University of Calgary, Calgary, AB, Canada
³Hematology/Oncology, University of Alberta, Edmonton, AB, Canada
⁴Hematology/Oncology, Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada
⁵Hematology, The Ottawa Hospital General Campus, Ottawa, ON, Canada
⁶Division of Hematology, Juravinski Cancer Centre, McMaster University, Hamilton, ON, Canada
⁷Centre Hospitalier Universitaire Dr. Georges-L.-Dumont, Moncton, NB, Canada
⁸Dr George-L Dumont Regional Hospital, Moncton, NB, Canada
⁹Jewish General Hospital, Montreal, QC, Canada
¹⁰Leukemia Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
¹¹McGill University Health Centre, Montreal, QC, Canada
¹²Vancouver General Hospital, Vancouver, BC, CAN
¹³CHU de Québec, Hôpital de l'Enfant-Jésus, Centre Universitaire d'Hématologie et d'Oncologie de Québec, Quebec City, QC, Canada
¹⁴Saskatoon Cancer Centre, Saskatoon, SK, Canada
¹⁵Department of Medical Oncology and Hematology, CancerCare Manitoba, Winnipeg, MB, Canada
¹⁶Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
¹⁷Odette Cancer Centre, Toronto, ON, CAN
¹⁸Odette Cancer Center, Toronto, ON, Canada
¹⁹St. Paul's Hospital University of British Columbia, Vancouver, BC, Canada
²⁰Sunnybrook Odette Cancer Center, Toronto, ON, Canada

Matteo Della Porta^1,2*, Uwe Platzbecker, MD³, Valeria Santini⁴, Guillermo Garcia-Manero, MD⁵, Rami S. Komrokji, MD⁶, Rodrigo Ito^7* and Pierre Fenaux, MD, PhD⁸

¹Cancer Center IRCCS Humanitas Research Hospital, Milan, Italy
²Department of Biomedical Sciences, Humanitas University, Milan, Italy
³Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany
⁴Azienda Ospedaliero Universitaria Careggi, University of Florence, Florence, Italy
⁵Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
⁶Moffitt Cancer Center, Tampa, FL
⁷Bristol Myers Squibb, Princeton, NJ
⁸Service d'Hématologie Séniors, Hôpital Saint-Louis, Université Paris 7, Paris, France

Suleyman Y Goksu, MD^1*, Jude Khatib, MD^1*, Busra N Bacik Goksu^1*, Rong Wang, PhD^2*, Prapti Patel, MD³, Madhuri Vusirkala, MD^1*, Suzanne Cole, MD^1*, Ahmet Seyhanli, M.D.^1*, Muhammet Ozer, MD^4*, Robert H. Collins, MD¹, Stephen Chung, MD¹, Amer M. Zeidan, MBBS, MHS⁵ and Yazan F. Madanat, MD¹

¹Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
²Yale University School of Public Health, New Haven, CT
³Simmons Comprehensive Cancer Center, Harold C Simmons Comprehensive Cancer Center, Dallas, TX
⁴Capital Health Regional Medical Center, Trenton, NJ
⁵Yale School of Medicine and Yale Cancer Center, Yale University, New Haven, CT

Sharon A Allen, MBBS^1,2, Eugene Ng, BSc^1*, Suzanne Edwards, GDipMStat, GDipMa, BN^3*, Uwe H Hahn, MBBS, MD, FRCPA^1,4*, Tatjana Banovic, MBBS, MD, PhD, FRCPA^1,5* and David M Ross, MBBS, PhD, FRACP, FRCPA^6,7,8*

¹SA Pathology, Adelaide, SA, Australia
²Department of Haematology, Royal Adelaide Hospital, Bowden, Australia
³The University of Adelaide, Adelaide, SA, Australia
⁴Royal Adelaide Hospital, Adelaide, Australia
⁵The Department of Clinical Immunology and Allergy, Royal Adelaide Hospital, Adelaide, Australia
⁶Department of Haematology, Royal Adelaide Hospital and SA Pathology, Adelaide, SA, Australia
⁷Department of Haematology, Flinders Medical Centre and University, Adelaide, SA, Australia
⁸Department of Haematology, Centre for Cancer Biology, SA Pathology, Adelaide, SA, Australia

Rashmi Kanagal-Shamanna, MD¹, Guillermo Montalban Bravo, MD², Panagiotis Katsonis^3*, Koji Sasaki, MD⁴, Caleb Class, PhD^5*, Christopher B. Benton, MD², Elias Jabbour, MD², Kelly S. Chien, MD², Rajyalakshmi Luthra, PhD^6*, Carlos E. Bueso-Ramos, MD, PhD¹, Tapan M. Kadia, MD⁴, Michael Andreeff, MD, PhD², Nicholas J. Short, MD⁴, Naval Daver, MD⁷, Mark Routbort, MD, PhD^1*, Joseph D. Khoury, MD¹, Keyur Patel, MD, PhD^8*, Irene Ganan-Gomez, PhD², Yue Wei, PhD², Gautam Borthakur, MD², Farhad Ravandi, MBBS⁴, Kim-Anh Do, PhD^5*, Kelly A. Soltysiak, PhD^2*, Olivier Lichtarge^3*, L. Jeffrey Medeiros, MD¹, Hagop M. Kantarjian, MD² and Guillermo Garcia-Manero, MD⁴

¹Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
³Baylor College of Medicine, Houston, TX
⁴Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX
⁶Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁷The University of Texas MD Anderson Cancer Center, Houston, TX
⁸University of Texas MD Anderson Cancer Center, Houston, TX

Jinming Song, MD, PhD^1*, Hailing Zhang, MD^2*, Xiaohui Zhang, MD, PhD², Mohammad Hussaini, MD^1*, Ning Dong, MD^3*, Lynn C Moscinski², Kenneth H. Shain, MD, PhD ⁴, Melissa Alsina, MD⁵, Taiga Nishihori, MD⁶ and Ling Zhang, MD^7*

¹Department of Pathology, Moffitt Cancer Center, Tampa, FL
²Department of Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
³Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁴Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Saint Petersburg, FL
⁵Department of Blood & Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Ctr. Hematologic Malignancies Program, Tampa, FL
⁶Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
⁷Department of Hematopathology and Laboratory Medicine, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL

Kiyomi Morita, MD, PhD¹, Hagop M. Kantarjian, MD¹, Guillermo Montalban Bravo, MD¹, Koji Sasaki, MD¹, Naval Daver, MD¹, Elias Jabbour, MD¹, Yesid Alvarado, MD¹, Kelly S. Chien, MD¹, Courtney D. DiNardo, MD, MSc¹, Farhad Ravandi, MBBS¹, Gautam Borthakur, MD¹, Prithviraj Bose, MD¹, Naveen Pemmaraju, MD¹, Kiran Naqvi, MD, MPH¹, Jorge E. Cortes, MD², Tapan M. Kadia, MD¹, Marina Konopleva, MD, PhD¹, Caitlin R. Rausch, PharmD^3*, Yvonne Gasior, RN^1* and Guillermo Garcia-Manero, MD¹

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Georgia Cancer Center, Augusta University, Augusta, GA
³Department of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX

Ikenna Onyekwere, BS^1*, Julie Perilla Garcia, BS, MS^2*, Kamal Menghrajani, MD³, Alexander Chan, MD^4*, Christopher Famulare, MS^5*, Minal A Patel, MPH^5*, John Philip, BA, MS^6*, Martin S. Tallman, MD ⁷, Virginia M. Klimek, MD⁸, Ross L. Levine, MD^3,9, Wenbin Xiao, MD, PhD⁴ and Jacob L Glass, MD, PhD^3,10

¹Weill Medical College of Cornell University, New York, NY
²Health Informatics, Memorial Sloan Kettering Cancer Center, New York, NY
³Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY
⁵Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY
⁶Department of Health Informatics, Memorial Sloan Kettering Cancer Center, New York, NY
⁷Memorial Sloan-Kettering Cancer Center, New York, NY
⁸Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁹Memorial Sloan Kettering Cancer Center, New York, NY
¹⁰Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, NY

Alex Sternberg, MRCP, MRCPath^1*, Rebecca H. Boucher, BSc, MSc, PhD^2*, Helen C Coulthard, BSc^2*, Manoj Raghavan, MBBS, PhD, MRCP, FRCPath^3*, Dominic J. Culligan, MD^4*, Aimee Jackson, BSc, MSc^2*, Catherine Cargo, MB, PhD^5*, Mike Dennis, MD⁶, Marlen Metzner, MSc^7*, Rachel Moore, BA^7*, David Bowen, MD⁸ and Paresh Vyas, MRCP, FRCP, FRCPath⁹

¹Department of Haematology, Great Western Hospital, Swindon, United Kingdom
²Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, United Kingdom
³Centre for Clinical Haematology, Queen Elizabeth Hospital, Birmingham, United Kingdom
⁴Department of Haematology, Aberdeen Royal Infirmary, Aberdeen, United Kingdom
⁵Department of Haematology, St. James' University Hospital, Leeds, United Kingdom
⁶The Christie NHS Foundation Trust, Manchester, United Kingdom
⁷Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom
⁸Department of Haematology, Leeds Teaching Hospitals, Leeds, United Kingdom
⁹MRC Molecular Haematology Unit, University of Oxford, Oxford, United Kingdom